INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $308,075 | -65.8% | 12,201 | -71.4% | 0.07% | -79.5% |
| Q2 2023 | $901,244 | +31.4% | 42,713 | +6.2% | 0.34% | -8.3% |
| Q1 2023 | $685,819 | +49.7% | 40,224 | +75.4% | 0.37% | +62.9% |
| Q4 2022 | $458,161 | -51.9% | 22,931 | -48.1% | 0.23% | -31.6% |
| Q3 2022 | $952,000 | +184.2% | 44,208 | +160.1% | 0.34% | +129.5% |
| Q2 2022 | $335,000 | -34.7% | 16,994 | -22.1% | 0.15% | -39.2% |
| Q1 2022 | $513,000 | -56.6% | 21,824 | -49.8% | 0.24% | +21.2% |
| Q4 2021 | $1,183,000 | -77.4% | 43,444 | -85.3% | 0.20% | -44.5% |
| Q3 2019 | $5,228,000 | -58.1% | 296,365 | -39.1% | 0.36% | -56.0% |
| Q2 2019 | $12,467,000 | +30.9% | 486,975 | +48.7% | 0.81% | +0.7% |
| Q1 2019 | $9,523,000 | -10.4% | 327,584 | -59.6% | 0.81% | -22.9% |
| Q4 2018 | $10,626,000 | – | 809,884 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |